Alvogen to acquire County Line Pharmaceuticals

PINE BROOK, N.J. — Pharmaceutical company Alvogen announced Monday that it would be acquiring Wis.-based specialty generics company County Line Pharmaceuticals. 

 

Alvogen’s purchase of the 9-year-old County Line for an undisclosed sum is aimed at strengthening the company’s position in the United States and is expected to bring in additional revenues of more than $100 million annually. County Line Pharmaceutical currently has 12 marketed products in the United States, as well as nine planned approvals and launches this year and eight expected approvals in 2017.